Cardiology

Hyperlipidemia Overview and the Clinical and Economic Burden

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

The Utilization of SGLT2 Inhibitors in the Treatment of Cardiovascular Disease, Diabetes, and Chronic Kidney D...

The Role of the Pharmacist in the Management of Hyperlipidemia

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

Recent Developments in the Management of Heart Failure With Preserved Ejection Fraction

Therapies in Lowering LDL-Cholesterol Levels for the Primary and Secondary Prevention of Atherosclerotic Cardi...

Updated Guidelines in the Management of Atrial Fibrillation and Application for Pharmacists

The Expanding Role of Nonstatin Therapies in Reducing LDL-Cholesterol Levels to Prevent and Manage ASCVD: A Re...

Elevating Cardiac Care: Insights From Pharmacists Across Practice Settings

The Evolving Treatment Paradigm for the Management of Pulmonary Arterial Hypertension: Strategies to Optimize ...

Lipoprotein(a) and Beyond: Emerging Paradigms in Atherosclerotic Cardiovascular Disease Prevention

Optimizing Care for Chronic Worsening Heart Failure: The Key Role of Pharmacists in Integrating Therapies

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care an...

Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

Exploring Advances in the Management of DOAC-Associated Bleeding With Reversal Agents: Role of the Health-Syst...